Skip to content
Clinical Trials – home

CHU Croix Rousse-Lyon

Verifiedinfo

France 103 Grande Rue De La Croix Rousse, 69317 Lyon, France

  • 50 trials recruiting
  • Metabolic dysfunction-associated steatohepatitis · Hepatocellular carcinoma · Asthma
  • Adults and children

About Specializations

CHU Croix Rousse-Lyon in Lyon, France specialises in clinical trials of conditions such as Metabolic dysfunction-associated steatohepatitis, Hepatocellular carcinoma, Asthma, Chronic obstructive pulmonary disease, and other specialisations. This site conducts important research.

Main research areas of the site

Otorhinolaryngology

The medical center is at the forefront of research in ear, nose, and throat diseases, focusing on innovative treatments and improving patient outcomes. The center's commitment to advancing the field is evident through its exploration of novel therapeutic approaches.

  • Idiopathic Purulent Oedematous Sinusitis
  • Quality of Life Improvements
  • Extended Antibiotic Therapies

By conducting multicenter randomized controlled trials, the center contributes significantly to the understanding and management of complex ENT conditions, enhancing the quality of life for patients through targeted interventions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
103 Grande Rue De La Croix Rousse69317 LyonFrance
Recruiting now
50 trials
Conditions studied
95
Partner status
Verified

More sites in LyonFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

117 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Pfizer Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Anastrozole
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bio89-100
  • Sponsor:89bio Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Hepatic fibrosis+2

Recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Efruxifermin
  • Sponsor:Akero Therapeutics Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Efruxifermin
  • Sponsor:Akero Therapeutics Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:LY3537031
  • Sponsor:Eli Lilly & Co.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Letrozole
  • Sponsor:Olema Pharmaceuticals Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.